These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 24154929)
1. Identification of the methylation of p14ARF promoter as a novel non-invasive biomarker for early detection of lung cancer. Li L; Shen Y; Wang M; Tang D; Luo Y; Jiao W; Wang Z; Yang R; Tian K Clin Transl Oncol; 2014 Jun; 16(6):581-9. PubMed ID: 24154929 [TBL] [Abstract][Full Text] [Related]
2. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients. Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076 [TBL] [Abstract][Full Text] [Related]
3. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699 [TBL] [Abstract][Full Text] [Related]
4. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069 [TBL] [Abstract][Full Text] [Related]
5. DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients. Nilsson TK; Löf-Öhlin ZM; Sun XF Int J Oncol; 2013 Jan; 42(1):127-33. PubMed ID: 23128528 [TBL] [Abstract][Full Text] [Related]
6. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer. Zhang Y; Miao Y; Yi J; Wang R; Chen L Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829 [TBL] [Abstract][Full Text] [Related]
8. Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. Xue Q; Zhou Y; Wan C; Lv L; Chen B; Cao X; Ju G; Huang Y; Ni R; Mao G Exp Mol Pathol; 2013 Dec; 95(3):313-8. PubMed ID: 23920144 [TBL] [Abstract][Full Text] [Related]
9. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma. Ishida E; Nakamura M; Ikuta M; Shimada K; Matsuyoshi S; Kirita T; Konishi N Oral Oncol; 2005 Jul; 41(6):614-22. PubMed ID: 15975525 [TBL] [Abstract][Full Text] [Related]
10. TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer. Wu D; Xiong L; Wu S; Jiang M; Lian G; Wang M Lung Cancer; 2012 Apr; 76(1):106-11. PubMed ID: 21983100 [TBL] [Abstract][Full Text] [Related]
11. Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer. Ko E; Lee BB; Kim Y; Lee EJ; Cho EY; Han J; Shim YM; Park J; Kim DH Clin Cancer Res; 2013 Mar; 19(5):1204-12. PubMed ID: 23319821 [TBL] [Abstract][Full Text] [Related]
12. Analysis of methylation patterns and expression profiles of p14ARF gene in patients with oral squamous cell carcinoma. Kordi-Tamandani DM; Moazeni-Roodi A; Rigi Ladez MA; Hashemi M; Birjandian E; Torkamanzehi A Int J Biol Markers; 2010; 25(2):99-103. PubMed ID: 20586029 [TBL] [Abstract][Full Text] [Related]
13. Frequency of P16INK4a and P14ARF genes methylation and its impact on bladder cancer cases in north Indian population. Ali Hosseini S; Sobti RC; Malekzadeh K; Singh SK; Joshi K Dis Markers; 2010; 28(6):361-8. PubMed ID: 20683150 [TBL] [Abstract][Full Text] [Related]
14. WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC). Baykara O; Demirkaya A; Kaynak K; Tanju S; Toker A; Buyru N Tumour Biol; 2010 Aug; 31(4):315-20. PubMed ID: 20480411 [TBL] [Abstract][Full Text] [Related]
15. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer. Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646 [TBL] [Abstract][Full Text] [Related]
16. TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer. Liu WB; Han F; Huang YS; Chen HQ; Chen JP; Wang DD; Jiang X; Yin L; Cao J; Liu JY Mol Carcinog; 2019 Apr; 58(4):474-487. PubMed ID: 30536447 [TBL] [Abstract][Full Text] [Related]
17. p14ARF promoter region methylation as a marker for gliomas diagnosis. He J; Qiao JB; Zhu H Med Oncol; 2011 Dec; 28(4):1218-24. PubMed ID: 20714943 [TBL] [Abstract][Full Text] [Related]
18. Determination of O⁶-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer. Ekim M; Caner V; Büyükpınarbaşılı N; Tepeli E; Elmas L; Bağcı G Genet Test Mol Biomarkers; 2011 May; 15(5):357-60. PubMed ID: 21288129 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer. Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874 [TBL] [Abstract][Full Text] [Related]
20. Methylation status of O6-methylguanine-DNA-methyl transferase promoter region in non-small-cell lung cancer patients with brain metastasis. Hashimoto K; Narita Y; Matsushita Y; Miyakita Y; Ono M; Kayama T; Shibui S Clin Transl Oncol; 2012 Jan; 14(1):31-5. PubMed ID: 22262716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]